Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
87,001,862
-
Total 13F shares
-
53,818,393
-
Share change
-
+1,361,898
-
Total reported value
-
$1,648,931,451
-
Put/Call ratio
-
14%
-
Price per share
-
$30.64
-
Number of holders
-
160
-
Value change
-
+$50,643,099
-
Number of buys
-
79
-
Number of sells
-
67
Institutional Holders of Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) as of Q3 2020
As of 30 Sep 2020,
Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) was held by
160 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
53,818,393 shares.
The largest 10 holders included
FMR LLC, EcoR1 Capital, LLC, BlackRock Inc., VANGUARD GROUP INC, Avoro Capital Advisors LLC, CITADEL ADVISORS LLC, STATE STREET CORP, VICTORY CAPITAL MANAGEMENT INC, EAGLE ASSET MANAGEMENT INC, and ADAGE CAPITAL PARTNERS GP, L.L.C..
This page lists
160
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.